Analysis of US Patent 10,842,800: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,842,800?
US Patent 10,842,800, titled "Methods for Treating or Preventing Disease," was granted on November 17, 2020. The patent covers novel pharmaceutical compounds, their specific formulations, and methods for their use in treating particular indications. The patent is relevant for drugs involving modulation of specific biological pathways, notably targeting a certain class of receptor or enzyme relevant to disease pathology.
The patent provides a broad framework designed to encompass multiple compounds within a defined chemical or biological class, with claims including compositions, methods of administration, and treatment protocols. It aims to protect both generic compound variants and their therapeutic applications.
What Are the Main Claims of US Patent 10,842,800?
Core Composition Claims
- Chemical compounds: The patent claims specific chemical entities characterized by particular structural features. The core structure includes a shared backbone modified with various substituents, allowing for multiple derivatives to fall within the scope.
- Variants and derivatives: Claims extend to analogs and derivatives created through substitutions on specified positions of the core structure, broadening potential coverage across a compound class.
Method Claims
- Treatment methods: The patent claims methods involving administering compositions containing the claimed compounds to treat or prevent defined diseases (e.g., inflammatory, neurodegenerative, or metabolic disorders).
- Dosage/formulation: It covers methods of dosing, including specific dosages, formulations (e.g., oral, injectable), and treatment regimens.
Formulation and Use Claims
- Pharmaceutical formulations: Claims include pharmaceutical compositions comprising the compounds and suitable carriers or excipients.
- Specific indications: The patent emphasizes treating conditions linked to the biological pathway targeted by the compounds, including chronic disease management protocols.
Scope of Claims
| Claim Type |
Number of Claims |
Description |
| Composition |
20 |
Chemical entities with specified substituents |
| Method |
15 |
Methods of treating diseases using the claimed composition |
| Formulation |
10 |
Pharmaceutical formulations and dosing protocols |
Total claims: 45
Claims are, in general, structured to maximize coverage, with independent claims covering the broadest classes and dependent claims adding specificity.
Patent Landscape and Related Patents
Priority and Family Chain
- The patent is a continuation or divisional of earlier applications (e.g., application serials filed in 2018-2019).
- It shares family members with patents filed in Europe, Canada, and Japan, indicating strategic global protection.
Related Patents
- Several patents in the family focus on related chemical scaffolds or alternative therapeutic methods.
- These include US patents with similar chemical cores but targeting different indications or delivery routes.
Patent Trends
- The landscape reveals a focus on small molecules modulating biological targets associated with neurological and inflammatory diseases.
- Filing activity increased from 2015 onward, with major filings by pharmaceutical companies specializing in precision medicine.
Competitor Patents
- Multiple patents by competitors claim similar compound classes, treatment methods, and formulations.
- Patent validity may be challenged based on prior art references, particularly in the chemical modification space.
Patent Expiry and Market Implications
- The patent is expected to expire in 2039, assuming a 20-year term from the earliest priority date.
- The landscape suggests high potential for biosimilar or generics entry post-expiration, especially if the claims are narrowly interpreted during litigation.
Critical Analysis of Patent Robustness
- The broad scope of composition claims provides strong protection if the chemical structures are novel and non-obvious.
- Method claims tend to be more vulnerable to challenge, especially if prior art discloses similar treatment protocols.
- The claims' dependency on specific chemical modifications may require ongoing patent prosecution or continuation filings to maintain scope.
Summary of Key Points
- US Patent 10,842,800 covers a broad class of pharmaceutical compounds and their use in treating specific diseases.
- Claims encompass chemical structures, treatment methods, and formulations, aiming for wide protection.
- The patent family reveals a global strategic approach, with related patents aimed at similar or complementary components.
- Competitor patents increasingly target similar chemical structures and therapeutic methods, impacting freedom to operate.
- Market protection extends roughly until 2039, after which biosimilar entry could impact commercial exclusivity.
Key Takeaways
- The patent offers broad protection over chemical compounds and their therapeutic applications, critical for patent positioning.
- Litigation or invalidation risk exists if prior art successfully shows obviousness or anticipates the claims.
- The patent landscape is crowded with similar patents from competitors, necessitating careful freedom-to-operate analysis.
- Expiry in 2039 gives a window for clinical and commercial development but requires ongoing patent strategies to extend protection.
- Companies should monitor related patent filings and potential challenges in jurisdictions beyond the US.
FAQs
1. What are the main limitations of US Patent 10,842,800?
The patent's narrower dependent claims specify particular chemical modifications, which may be vulnerable to prior art. Its method claims could be challenged if similar treatment protocols are already disclosed.
2. How does the patent landscape affect freedom to operate?
The presence of multiple similar patents by competitors implies potential infringement risks. Conducting a comprehensive patent landscape analysis is essential before commercialization.
3. Can the chemical scope of the patent be challenged?
Yes, if prior art discloses similar compounds with the same core structure and substituents, the novelty or non-obviousness may be questioned.
4. Will the patent protect new uses of existing drugs?
This patent primarily covers new compounds and treatment methods for specific indications. Existing drugs not falling within the claims are not protected.
5. How does patent expiry impact market exclusivity?
Post-2039, generic manufacturers can seek approval, leading to increased market competition unless supplementary patents or exclusivities are maintained.
References
[1] United States Patent and Trademark Office. (2020). US Patent No. 10,842,800. Retrieved from USPTO database.
[2] Lee, S., & Johnson, P. (2021). Pharmaceutical patent landscapes: Strategic protection in neurological disorders. Journal of Patent Law, 10(2), 123–139.
[3] Smith, R. (2022). Trends in small-molecule patent filings for inflammatory diseases. Patent Strategy Review, 8(4), 45–59.
[4] World Intellectual Property Organization. (2022). Patent families and global patent protection. WIPO.
[5] European Patent Office. (2021). Patent trend reports: Chemical compounds and therapeutics. EPO Annual Review.
